2 results
Approved WMOCompleted
The primary objectives of the Phase Ib portion of the study are as follows:* To assess the safety and tolerability of the combination of polatuzumab vedotin with bendamustine and rituximab (BR) or bendamustine and obinutuzumab (BG) when administered…
Approved WMOCompleted
Primary: • To analyze the stability of the MHP using R.S.A to predict the long term survival.Secondary• To analyze the short term (1 year) safety of the MHP compared to the Stanmore hip replacement.• To analyze the short term (1 year) efficacy of…